Acute cardiomyopathy as a consequence of treatment with interleukin-2 and interferon-alpha in a patient with metastatic carcinoma of the breast.
Azar
J J
JJ
Department of Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston 77030.
Rheriault
R L
RL
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D002311:Cardiomyopathy, Dilated / Q000139:chemically induced*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage; D007376:Interleukin-2 / Q000008:administration & dosage; D008875:Middle Aged; D009362:Neoplasm Metastasis
D016898:Interferon-alpha; D007376:Interleukin-2